HIF1A and breast carcinoma: Here, we present evidence that 17β-oestradiol (E2), the most potent form of circulating oestrogen, stimulates steroid-starved ERα-positive breast cancer cells by rapid accumulation of HIF-1α and activates HIF1 through its non-genomic signalling.